Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

Caretaker Medical Announces Health Canada Clearance Under the COVID-19 Interim Authorization


CHARLOTTESVILLE, Va., Dec. 3, 2020 /PRNewswire/ -- Caretaker Medical, a leader in clinical-grade wireless patient monitoring and maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Sensor to remotely measure "Beat by Beat" Continuous Blood Pressure and multiple vital signs, announces Health Canada clearance for import and sale under the COVID-19 Medical Device Authorization.

The clearance authorizes Caretaker to immediately begin sales throughout Canada to help clinicians safely monitor quarantine patients without ever entering the room, augment overburdened clinical resources, reduce the use of PPE, and enable safe "clinically distanced" monitoring.

The Caretaker® patient monitor measures continuous, uninterrupted Blood Pressure, Heart Rate, Respiration Rate, SpO2, and other Vital Signs across the full continuum of care in a completely wire-free form factor, allowing clinicians to remotely view ICU-Quality data while safely distanced from contagious patients.  

Jeff Pompeo, President & CEO of Caretaker Medical, said, "Together with our distribution partner, MedTach, we are excited to bring Caretaker into the Canadian clinical market, to address the need for continuous, ICU-quality wireless patient monitoring remotely while maximizing safety of both patient and clinician."

Greig Findley, MedTach President, added, "We are proud to partner with Caretaker Medical and are thrilled of the recent Health Canada licensing authorization. The Caretaker is a game-changer bringing the capability of a highly portable continuous blood pressure and vital signs monitoring system to patients inside and outside the hospital walls."

The Caretaker wireless vital signs and continuous Beat-by-Beat remote monitoring platform is FDA Cleared, CE-Mark certified and is available for purchase from the company or its network of global distributors. Hospitals and clinics are successfully using Caretaker to wirelessly monitor Quarantined COVID-19 patients and also monitor patients across a wide range of clinical settings, including surgery, ICU, ER, EMS/Ambulance, dialysis, infusion, Labor & Delivery, clinical trials, and remote patient monitoring.

About Caretaker Medical:  Caretaker Medical is a wireless medical device firm focused on developing affordable, innovative, wireless patient monitoring solutions that improve outcomes, increase clinician productivity, and maximize patient compliance without compromising patient comfort.

The wearable Caretaker® patient monitor enables uninterrupted wire-free and electrode-free real-time vital signs monitoring throughout the full continuum of care using a low pressure finger sensor and patented Pulse Decomposition Analysis technology non-invasively measures continuous Beat-by-Beat Blood Pressure, Heart Rate, Respiration Rate and other parameters for remote display on the Caretaker Tablet App and other Remote Data Displays. The Caretaker CNIBP technology delivers "ICU Quality" continuous measurements without intrusive arterial catheters or cumbersome wires, giving clinicians the ability to recognize deteriorating hemodynamic trends earlier with more lead time for intervention while providing a much more comprehensive view of a patient's vital signs status.

More information is available at www.CareTakerMedical.net

About MedTach: MedTach is a leading Canadian medical technology distribution company focused on delivering transformative tools to clinicians and researchers. ?We partner with innovative companies from around the world to introduce solutions that will improve medical procedures, research, and patient outcomes.  More information is available at https://www.medtach.com

Media Contact:
Jeff Pompeo
[email protected]
434-409-1945

SOURCE Caretaker Medical


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: